top of page
PLASBIO
Background
Non-clinical market size
The non-clinical market is expanding worldwide, driven by increasing demand for pharmaceutical and medical technology.
Non-clinical Market Status
In the post-COVID-19 era, global growth in the non-clinical market is driven by increased
demand for pharmaceutical and medical technology, along with the expansion of the AI drug development market.
Ripple effect
Intellectual Property Rights
PLASBIO
a company that creates
new values in technological
convergence
Patent applications and registrations in Korea
21
Overseas
patent (US)
2
PCT
5
Trademark
rights
6
앵커 6
PLASBIO is a technology-oriented corporation that builds lab
animal study automation solution to move with the times of
the steadily growing biotech market.
We have grown to become a company that creates exceptional
values with competitive technologies of artificial intelligence
and 3D printing.
2020
Founded 2020.11.11 (Plasbio Inc.)
Selected as a project of the Ministry of SMEs and Startups-Microsoft Global Cooperation Program
Moved into Jeonju Camtik Institute of Technology
2021
Korea Biotechnology Research Institute Family Business
Selected as TIPS R&D
Infobank, TheNextrap PreA
KB Investment Seed
Venture company certification
Selected as a Jeollabukbuk-do Promising Company
Joint research with Johns Hopkins nanotechnology institute
Supplier to KAIST Bio Synthesis Research Center
Signed MOU with Oceans Bio, EVIO
Signed MOU, NDA with Btree
MOU with Gangwon National University College of Pharmacy
2022
Society of Neuroscience 2022 Announcement
Winner of 73rd AALAS Outstanding Research Poster Award
KBSI Convergence Innovation Center
Launched BIOKOREA 2022 smart inject
Established Daejeon Branch (June 2022)
IBK Changgong Daejeon 1
Selected as a cross-ministry project
Signed MOU with Hubet
MOU with Aju University College of Pharmacy
2023
2024
2025
First Penguin Selected by Credit Guarantee Fund
Selected as an AI voucher provider
Selected for NVIDIA's inception program
Selected as Jeollabuk-do Innovation Startup 100
CES 2024 Innovation Award Honorees
U.S. patent registered (brain inject)
2025 CES Jeonbuk Joint Pavilion
Participation in KASBP and BIO USA IR
bottom of page